RHABDOMYOSARCOMA
Clinical trials for RHABDOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new RHABDOMYOSARCOMA trials appear
Sign up with your email to follow new studies for RHABDOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Chemo showdown: short High-Dose vs long Low-Dose for childhood muscle cancer
Disease control Not yet recruitingThis study compares two chemotherapy approaches for people up to age 50 with newly diagnosed intermediate-risk rhabdomyosarcoma, a type of muscle cancer. One group gets a higher dose of chemo over a shorter time, while the other gets a lower dose over a longer time plus extra mai…
Matched conditions: RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
Promising combo aims to fight tough childhood cancer
Disease control Not yet recruitingThis study tests whether adding all-trans retinoic acid (ATRA) to standard VAC chemotherapy helps people with intermediate-to-high-risk rhabdomyosarcoma live longer without the cancer growing. About 106 participants aged 14 to 60 who have not had prior treatment will take part. T…
Matched conditions: RHABDOMYOSARCOMA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Engineered immune cells take on Hard-to-Treat solid tumors
Disease control Not yet recruitingThis early-stage study tests a new treatment for adults with solid tumors that have come back or not responded to standard therapy. The treatment uses a patient's own immune cells, which are modified in a lab to better recognize and attack cancer cells that carry a protein called…
Matched conditions: RHABDOMYOSARCOMA
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
New app aims to guide young cancer survivors through After-Treatment challenges
Knowledge-focused Not yet recruitingThis study is testing a mobile app called my.naviGATE for teens and young adults (ages 15-24) who have finished cancer treatment. The app provides personalized education, peer support, and tracks how patients are doing. Researchers want to see if using the app helps patients feel…
Matched conditions: RHABDOMYOSARCOMA
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Smart scans keep proton therapy on target for kids with cancer
Knowledge-focused Not yet recruitingThis study looks at whether taking extra CT or MRI scans during proton therapy for children with solid tumors or Hodgkin's lymphoma can help doctors adjust the treatment plan if the tumor or body changes shape. About 100 children will get weekly or every-other-week scans to check…
Matched conditions: RHABDOMYOSARCOMA
Phase: NA • Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC